Literature DB >> 27076634

Cistrome-based Cooperation between Airway Epithelial Glucocorticoid Receptor and NF-κB Orchestrates Anti-inflammatory Effects.

Vineela Kadiyala1, Sarah K Sasse1, Mohammed O Altonsy2, Reena Berman1, Hong W Chu1, Tzu L Phang3, Anthony N Gerber4.   

Abstract

Antagonism of pro-inflammatory transcription factors by monomeric glucocorticoid receptor (GR) has long been viewed as central to glucocorticoid (GC) efficacy. However, the mechanisms and targets through which GCs exert therapeutic effects in diseases such as asthma remain incompletely understood. We previously defined a surprising cooperative interaction between GR and NF-κB that enhanced expression of A20 (TNFAIP3), a potent inhibitor of NF-κB. Here we extend this observation to establish that A20 is required for maximal cytokine repression by GCs. To ascertain the global extent of GR and NF-κB cooperation, we determined genome-wide occupancy of GR, the p65 subunit of NF-κB, and RNA polymerase II in airway epithelial cells treated with dexamethasone, TNF, or both using chromatin immunoprecipitation followed by deep sequencing. We found that GR recruits p65 to dimeric GR binding sites across the genome and discovered additional regulatory elements in which GR-p65 cooperation augments gene expression. GR targets regulated by this mechanism include key anti-inflammatory and injury response genes such as SERPINA1, which encodes α1 antitrypsin, and FOXP4, an inhibitor of mucus production. Although dexamethasone treatment reduced RNA polymerase II occupancy of TNF targets such as IL8 and TNFAIP2, we were unable to correlate specific binding sequences for GR or occupancy patterns with repressive effects on transcription. Our results suggest that cooperative anti-inflammatory gene regulation by GR and p65 contributes to GC efficacy, whereas tethering interactions between GR and p65 are not universally required for GC-based gene repression.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  A20; ChIP-sequencing (ChIP-seq); NF-κB (NF-KB); SERPINA1; airway; asthma; chromatin immunoprecipitation (ChiP); glucocorticoid receptor; transcription enhancer

Mesh:

Substances:

Year:  2016        PMID: 27076634      PMCID: PMC4933445          DOI: 10.1074/jbc.M116.721217

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

1.  The murine orthologue of human antichymotrypsin: a structural paradigm for clade A3 serpins.

Authors:  Anita J Horvath; James A Irving; Jamie Rossjohn; Ruby H Law; Stephen P Bottomley; Noelene S Quinsey; Robert N Pike; Paul B Coughlin; James C Whisstock
Journal:  J Biol Chem       Date:  2005-09-04       Impact factor: 5.157

Review 2.  Drug insight: selective agonists and antagonists of the glucocorticoid receptor.

Authors:  Andrew McMaster; David W Ray
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-02

3.  The hypersensitive glucocorticoid response specifically regulates period 1 and expression of circadian genes.

Authors:  Timothy E Reddy; Jason Gertz; Gregory E Crawford; Michael J Garabedian; Richard M Myers
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

4.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

5.  Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation.

Authors:  Mohammed O Altonsy; Sarah K Sasse; Tzu L Phang; Anthony N Gerber
Journal:  J Biol Chem       Date:  2014-02-05       Impact factor: 5.157

6.  Response Element Composition Governs Correlations between Binding Site Affinity and Transcription in Glucocorticoid Receptor Feed-forward Loops.

Authors:  Sarah K Sasse; Zheng Zuo; Vineela Kadiyala; Liyang Zhang; Miles A Pufall; Mukesh K Jain; Tzu L Phang; Gary D Stormo; Anthony N Gerber
Journal:  J Biol Chem       Date:  2015-06-18       Impact factor: 5.157

7.  Global strategy for asthma management and prevention: GINA executive summary.

Authors:  E D Bateman; S S Hurd; P J Barnes; J Bousquet; J M Drazen; J M FitzGerald; P Gibson; K Ohta; P O'Byrne; S E Pedersen; E Pizzichini; S D Sullivan; S E Wenzel; H J Zar
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

8.  A user's guide to the encyclopedia of DNA elements (ENCODE).

Authors: 
Journal:  PLoS Biol       Date:  2011-04-19       Impact factor: 8.029

9.  Genomic redistribution of GR monomers and dimers mediates transcriptional response to exogenous glucocorticoid in vivo.

Authors:  Hee-Woong Lim; N Henriette Uhlenhaut; Alexander Rauch; Juliane Weiner; Sabine Hübner; Norbert Hübner; Kyoung-Jae Won; Mitchell A Lazar; Jan Tuckermann; David J Steger
Journal:  Genome Res       Date:  2015-05-08       Impact factor: 9.043

10.  Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepression-dependent mechanisms.

Authors:  Elizabeth M King; Joanna E Chivers; Christopher F Rider; Anne Minnich; Mark A Giembycz; Robert Newton
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more
  19 in total

Review 1.  Glucocorticoid receptors: finding the middle ground.

Authors:  Sofie J Desmet; Karolien De Bosscher
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

Review 2.  Glucocorticoid and cytokine crosstalk: Feedback, feedforward, and co-regulatory interactions determine repression or resistance.

Authors:  Robert Newton; Suharsh Shah; Mohammed O Altonsy; Antony N Gerber
Journal:  J Biol Chem       Date:  2017-03-10       Impact factor: 5.157

Review 3.  Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update.

Authors:  Robert Newton; Mark A Giembycz
Journal:  Br J Pharmacol       Date:  2016-11-09       Impact factor: 8.739

4.  DUSP1 Maintains IRF1 and Leads to Increased Expression of IRF1-dependent Genes: A MECHANISM PROMOTING GLUCOCORTICOID INSENSITIVITY.

Authors:  Suharsh Shah; Elizabeth M King; Mahmoud M Mostafa; Mohammed O Altonsy; Robert Newton
Journal:  J Biol Chem       Date:  2016-08-22       Impact factor: 5.157

Review 5.  Important lessons learned from studies on the pharmacology of glucocorticoids in human airway smooth muscle cells: Too much of a good thing may be a problem.

Authors:  Yassine Amrani; Reynold A Panettieri; Patricia Ramos-Ramirez; Dedmer Schaafsma; Klaudia Kaczmarek; Omar Tliba
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

6.  Glucocorticoid Receptor ChIP-Seq Identifies PLCD1 as a KLF15 Target that Represses Airway Smooth Muscle Hypertrophy.

Authors:  Sarah K Sasse; Vineela Kadiyala; Thomas Danhorn; Reynold A Panettieri; Tzu L Phang; Anthony N Gerber
Journal:  Am J Respir Cell Mol Biol       Date:  2017-08       Impact factor: 6.914

7.  Facilitating Analysis of Publicly Available ChIP-Seq Data for Integrative Studies.

Authors:  Avantika R Diwadkar; Mengyuan Kan; Blanca E Himes
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

8.  Glucocorticoid and TNF signaling converge at A20 (TNFAIP3) to repress airway smooth muscle cytokine expression.

Authors:  Sarah K Sasse; Mohammed O Altonsy; Vineela Kadiyala; Gaoyuan Cao; Reynold A Panettieri; Anthony N Gerber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-01       Impact factor: 5.464

Review 9.  Insights into glucocorticoid responses derived from omics studies.

Authors:  Mengyuan Kan; Blanca E Himes
Journal:  Pharmacol Ther       Date:  2020-09-08       Impact factor: 12.310

10.  Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.

Authors:  Clarissa S Santoso; Zhaorong Li; Jaice T Rottenberg; Xing Liu; Vivian X Shen; Juan I Fuxman Bass
Journal:  Front Pharmacol       Date:  2021-06-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.